Form 4 filed by Burrows Scott L
Burrows Scott L filed this Form 4 on Spyre Therapeutics, Inc. with 10 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-03 01:29:27 UTC.
- Accession
- 0001636282-26-000117
- Filer
- CIK 1853327
- Filed
- 2026-10-02
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
Issuer and reporting owners
Issuer: Spyre Therapeutics, Inc. (CIK 1636282)
- Burrows Scott L officer (Chief Financial Officer)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-09-30 | M exercised | +17,500 | $14.5 | 97,262 | D |
| Common Stock | 2026-09-30 | S sold | -17,500 | $89.89 | 79,762 | D |
| Common Stock | 2026-10-01 | M exercised | +7,500 | $14.5 | 87,262 | D |
| Common Stock | 2026-10-01 | S sold | -600 | $89.07 | 86,662 | D |
| Common Stock | 2026-10-01 | S sold | -1,500 | $90.27 | 85,162 | D |
| Common Stock | 2026-10-01 | S sold | -2,100 | $91.92 | 83,062 | D |
| Common Stock | 2026-10-01 | S sold | -3,071 | $92.95 | 79,991 | D |
| Common Stock | 2026-10-01 | S sold | -229 | $93.57 | 79,762 | D |
| Stock Option (Right to Buy) derivative | 2026-09-30 | M exercised | -17,500 | $0 | 319,857 | D |
| Stock Option (Right to Buy) derivative | 2026-10-01 | M exercised | -7,500 | $0 | 312,357 | D |